PropertyValue
?:abstract
  • To fight antibiotic resistance, novel drugs are urgently needed. Regulatory agencies are addressing the economic problems and offer new incentives for developing new antibiotics.
?:creator
?:doi
  • 10.15252/embr.202050807
?:doi
?:journal
  • EMBO_reports
?:license
  • unk
?:pmid
?:pmid
  • 32449264.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • A war of attrition against antibiotic resistance: Current strategies try to keep antibiotic resistance at bay and further encourage research to produce genuinely novel antibacterials.
?:type
?:year
  • 2020-05-24

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/i0f40go1>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/i0f40go1>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all